Can Text Messages Really Improve Endocrine Therapy Adherence?
from Breast Cancer Trials Hosted by Breast Cancer Trials
Can Text Messages Really Improve Endocrine Therapy Adherence? Dr Anna Singleton is a Senior Research Fellow at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. Her research focuses on co-designing and implementing accessible and scalable digital health services to improve health outcomes for people living with and beyond cancer. We spoke with her about the EMPOWER-SMS clinical trial and what it aims to achieve for breast cancer patients. Like this episode? Follow Breast Cancer Trials on Social Media: Instagram: @breastcancertrials Facebook: Breast Cancer Trials LinkedIn: Breast Cancer Trials X: @BCTrialsANZ Guest: Dr Anna Singleton Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about clinical trials research. Find out more: www.breastcancertrials.org.au
Embed this episode
No transcript yet.